BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2792186)

  • 21. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
    Gorelik E; Jay G; Kwiatkowski B; Herberman RB
    J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells.
    Gorelik L; Bar-Dagan Y; Mokyr MB
    J Immunol; 1996 Jun; 156(11):4298-308. PubMed ID: 8666801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive expression of tumor necrosis factor-alpha in cytotoxic cells of teleosts and its role in regulation of cell-mediated cytotoxicity.
    Praveen K; Evans DL; Jaso-Friedmann L
    Mol Immunol; 2006 Feb; 43(3):279-91. PubMed ID: 16199264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB; Gutterman JU; Grimm EA
    Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor.
    Gorelik E; Begoviĉ M; Duty L; Herberman RB
    Cancer Res; 1991 Mar; 51(5):1521-8. PubMed ID: 1997193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.
    Ab BK; Kiessling R; Van Embden JD; Thole JE; Kumararatne DS; Pisa P; Wondimu A; Ottenhoff TH
    Eur J Immunol; 1990 Feb; 20(2):369-77. PubMed ID: 1690136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis.
    Bonetti B; Valdo P; Ossi G; De Toni L; Masotto B; Marconi S; Rizzuto N; Nardelli E; Moretto G
    Glia; 2003 Aug; 43(2):141-8. PubMed ID: 12838506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
    Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the tumor necrosis factor locus is not necessary for the cytolytic activity of T lymphocytes.
    Jongeneel CV; Nedospasov SA; Plaetinck G; Naquet P; Cerottini JC
    J Immunol; 1988 Mar; 140(6):1916-22. PubMed ID: 3257993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.
    Yamamoto RS; Ware CF; Granger GA
    J Immunol; 1986 Sep; 137(6):1878-84. PubMed ID: 2943806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
    Remels L; Fransen L; Huygen K; De Baetselier P
    J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
    Mueller RB; Skapenko A; Grunke M; Wendler J; Stuhlmuller B; Kalden JR; Schulze-Koops H
    Arthritis Rheum; 2005 Feb; 52(2):451-60. PubMed ID: 15692975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
    van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
    Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic antitumor effects of topoisomerase inhibitors and natural cell-mediated cytotoxicity.
    Utsugi T; Demuth S; Hanna N
    Cancer Res; 1989 Mar; 49(6):1429-33. PubMed ID: 2538225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS; Thiele DL; Lipsky PE
    J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells.
    Erb P; Grogg D; Troxler M; Kennedy M; Fluri M
    J Immunol; 1990 Feb; 144(3):790-5. PubMed ID: 1967273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.
    Kalinichenko VV; Mokyr MB; Graf LH; Cohen RL; Chambers DA
    J Immunol; 1999 Sep; 163(5):2492-9. PubMed ID: 10452985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.